Shipping Fees May Apply Frequently Asked Questions Still have questions
What changes is the dose, the frequency, and the concentration, not the injection technique
FDA Ruling Overview The FDA declared on February 21, 2025, that the Semaglutide shortage, used in weight loss drugs like Wegovy and Ozempic, is resolved (FDA Clarifies Policies for Compounders)
With ongoing injury, stellate cells become chronically activated, laying down scar tissue that stiffens the liver and reduces its regenerative potential
At Tyrance Orthopedics & Sports Medicine, we help you unlock the healing potential of peptides safely and ethically
XPHOZAH was approved in mainland China on February 20, 2025, and was approved for the treatment of hyperphosphatemia in Japan and the United States in 2023